184 related articles for article (PubMed ID: 28570499)
1. Stable Remission of Multiple Chemical Sensitivity Syndrome and Major Depression With Citalopram and 1-Month Deep Transcranial Magnetic Stimulation: A Case Report.
Del Casale A; Rapinesi C; Kotzalidis GD; Sorice S; Padovano A; Gentile G; Angeletti G; Ferracuti S; Sani G; Pompili M; Simmaco M; Girardi P
J ECT; 2017 Sep; 33(3):e27-e29. PubMed ID: 28570499
[No Abstract] [Full Text] [Related]
2. [Higher probability of remission with escitalopram in comparison to citalopram].
Linné AB; Hallberg I
Lakartidningen; 2009 Apr 28-May 12; 106(18-19):1292; discussion 1292-3. PubMed ID: 19537504
[No Abstract] [Full Text] [Related]
3. Repetitive transcranial magnetic stimulation in combination with citalopram in young patients with first-episode major depressive disorder: a double-blind, randomized, sham-controlled trial.
Huang ML; Luo BY; Hu JB; Wang SS; Zhou WH; Wei N; Hu SH; Xu Y
Aust N Z J Psychiatry; 2012 Mar; 46(3):257-64. PubMed ID: 22391283
[TBL] [Abstract][Full Text] [Related]
4. Successful use of a selective serotonin reuptake inhibitor in a patient with multiple chemical sensitivities.
Andiné P; Rönnbäck L; Järvholm B
Acta Psychiatr Scand; 1997 Jul; 96(1):82-3. PubMed ID: 9259230
[TBL] [Abstract][Full Text] [Related]
5. Escitalopram for severe asthma and major depressive disorder: a randomized, double-blind, placebo-controlled proof-of-concept study.
Brown ES; Howard C; Khan DA; Carmody TJ
Psychosomatics; 2012; 53(1):75-80. PubMed ID: 22221724
[TBL] [Abstract][Full Text] [Related]
6. Repetitive transcranial magnetic stimulation (rTMS) in combination with escitalopram in patients with treatment-resistant major depression: a double-blind, randomised, sham-controlled trial.
Bretlau LG; Lunde M; Lindberg L; Undén M; Dissing S; Bech P
Pharmacopsychiatry; 2008 Mar; 41(2):41-7. PubMed ID: 18311683
[TBL] [Abstract][Full Text] [Related]
7. Transient citalopram-induced auditory hallucinations in a patient with Parkinson's disease and depression.
Wand AP
Aust N Z J Psychiatry; 2012 Feb; 46(2):178. PubMed ID: 22311539
[No Abstract] [Full Text] [Related]
8. Improvement of Escitalopram-Induced Sweating With Citalopram.
Kolli V; Rainville CT
Prim Care Companion CNS Disord; 2017 Apr; 19(2):. PubMed ID: 28426928
[No Abstract] [Full Text] [Related]
9. Tardive dyskinesia associated with long-term administration of escitalopram and itopride in major depressive disorder.
Park YM; Lee HJ; Kang SG; Choo CS; Cho JH
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar; 33(2):380-1. PubMed ID: 19121360
[No Abstract] [Full Text] [Related]
10. A Danish cost-effectiveness model of escitalopram in comparison with citalopram and venlafaxine as first-line treatments for major depressive disorder in primary care.
Sørensen J; Stage KB; Damsbo N; Le Lay A; Hemels ME
Nord J Psychiatry; 2007; 61(2):100-8. PubMed ID: 17454724
[TBL] [Abstract][Full Text] [Related]
11. A randomized trial of citalopram versus placebo in outpatients with asthma and major depressive disorder: a proof of concept study.
Brown ES; Vigil L; Khan DA; Liggin JD; Carmody TJ; Rush AJ
Biol Psychiatry; 2005 Dec; 58(11):865-70. PubMed ID: 15993860
[TBL] [Abstract][Full Text] [Related]
12. Wolf-Hirschhorn (4p-)syndrome in a near adult with major depression; successful treatment with citalopram.
Verhoeven WM; Moog U; Wagemans AM; Tuinier S
Genet Couns; 2002; 13(3):297-301. PubMed ID: 12416637
[TBL] [Abstract][Full Text] [Related]
13. Palpebral twitching in a depressed adolescent on citalopram.
Rojas VM; Silva R
J Child Adolesc Psychopharmacol; 2001; 11(3):295-9. PubMed ID: 11642480
[TBL] [Abstract][Full Text] [Related]
14. Clinical milestones predict symptom remission over 6-month and choice of treatment of patients with major depressive disorder (MDD).
Wade AG; Schlaepfer TE; Andersen HF; Kilts CD
J Psychiatr Res; 2009 Feb; 43(5):568-75. PubMed ID: 18954875
[TBL] [Abstract][Full Text] [Related]
15. A pharmacoeconomic evaluation of escitalopram versus citalopram in the treatment of severe depression in the United Kingdom.
Wade AG; Toumi I; Hemels ME
Clin Ther; 2005 Apr; 27(4):486-96. PubMed ID: 15922821
[TBL] [Abstract][Full Text] [Related]
16. Citalopram and escitalopram in the treatment of major depressive disorder: a pooled analysis of 3 clinical trials.
Li H; Li T; Li G; Luo J
Ann Clin Psychiatry; 2014 Nov; 26(4):281-7. PubMed ID: 25401715
[TBL] [Abstract][Full Text] [Related]
17. [Citalopram (Cipramil) in monotherapy of depressed outpatients].
Landowski J
Psychiatr Pol; 2000; 34(3 Suppl):1-8. PubMed ID: 11055187
[TBL] [Abstract][Full Text] [Related]
18. Repetitive Transcranial Magnetic Stimulation for the Treatment of Major Depression in a Patient With an Intracranial Space-Occupying Lesion: A Case Report of Safety.
Surya S; Rosenquist PB; McCall WV
J ECT; 2016 Mar; 32(1):62-4. PubMed ID: 25945969
[TBL] [Abstract][Full Text] [Related]
19. Resolution of Citalopram Sexual Adverse Effects With Low Dose of Cariprazine: A Case Report.
Dieci M; Trama A; Mansi G
Clin Neuropharmacol; 2020; 43(5):164-165. PubMed ID: 32947429
[TBL] [Abstract][Full Text] [Related]
20. A double-blind, placebo-controlled treatment trial of citalopram for major depressive disorder in older patients with heart failure: the relevance of the placebo effect and psychological symptoms.
Fraguas R; da Silva Telles RM; Alves TC; Andrei AM; Rays J; Iosifescu DV; Wajngarten M
Contemp Clin Trials; 2009 May; 30(3):205-11. PubMed ID: 19470312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
